Heterocyclic compound which may be used as a medicine having p38 MAP kinase inhibitory activity

Assignee

• Mitsubishi Tanabe Pharma

Inventors

• Akira Kubo (4 patents)
• Tetsu Nakane (4 patents)
• Tatsuo Nakajima (7 patents)
• Takanori Murakami (1 patents)
• Hidetaka Miyoshi (3 patents)
• Akihito Ogasawara (3 patents)

View full patent text on Google Patents →